Tuned for the writing your TA actually does.
Module rules are necessary but not sufficient. Each therapeutic area carries its own conventions — endpoint vocabulary, assessment frameworks, regulator preferences. Asthra carries TA-specific tunings on top of every module type.
Twelve areas, today.
Active deployments and pilot engagements span these therapeutic areas. Each comes with a tuned vocabulary set, regulator-specific writing conventions, and references curated by domain advisors.
Oncology
Endpoint conventions for ORR, PFS, OS; tumor-type vocabularies; immunotherapy AESI patterns. Largest pilot footprint to date.
Immunology
IBD, RA, psoriasis, atopic conditions. Tuning around composite endpoints and durable-response narratives.
Cardiovascular & metabolic
MACE adjudication language, glycemic-control framing, large-trial conventions. Common with sponsors running outcomes trials.
Neurology & neuroscience
Cognitive scales, MRI biomarker conventions, slow-progression narrative patterns. Includes neurodegenerative and movement disorders.
Rare disease
Small-N narrative discipline, natural-history referencing, accelerated-pathway framing. Heavy on sentence-level provenance.
Vaccines & infectious disease
Immunogenicity endpoint conventions, AESI patterns, post-marketing surveillance framing. Aggressive aggregate cadence.
Women's health
Reproductive endpoint vocabulary, contraception-language standards, special-population framing.
Pediatrics
PIP-aligned narrative, age-stratified safety framing, growth-and-development endpoint conventions.
Hematology
Hematologic-response criteria (IWG, IMWG), MRD framing, transplant-context narratives.
Medical devices
EU MDR-aligned CER drafting, equivalence framing, post-market surveillance synthesis. Notified-body verifiable.
Cell & gene therapy
Long-term follow-up framing, replication-competent virus surveillance, manufacturing-comparability narratives.
CMC across modalities
Small molecule, biologic, biosimilar, ATMP drafting. Modality-aware Module 3 templates.
Tunings come from the writers — not from us guessing.
Each therapeutic-area tuning is built with two or three medical writers and a regulatory advisor from that area, then validated against real submissions. Asthra's job is to encode their judgment, not to substitute for it.
Don't see your area? We add new TAs in roughly six-week sprints. Tell us what you write and we'll scope a co-development pilot.
Pilot in your TA.
30 days, your real document, your therapeutic area. We'll work with your team to tune the rules before drafting begins.